Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study

East Asians are reportedly at high risk of anticoagulant-related bleeding; therefore, some physicians prefer to prescribe low-dose direct oral anticoagulants (DOACs). Little is known about the therapeutic effectiveness and safety of off-label reduced-dose apixaban in East Asians with nonvalvular atr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, I-Chih, Chang, Wei-Ting, Hsu, Po-Chao, Yeh, Ya-Lan, Zheng, Syuan, Huang, Yuan-Chi, Lin, Chih-Hsien, Tsai, Liang-Miin, Lin, Li-Jen, Liu, Ping-Yen, Liu, Yen-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202542/
https://www.ncbi.nlm.nih.gov/pubmed/34115024
http://dx.doi.org/10.1097/MD.0000000000026272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202542/
https://www.ncbi.nlm.nih.gov/pubmed/34115024
http://dx.doi.org/10.1097/MD.0000000000026272

Ejemplares similares